Care of the Postablation Patient: Surveillance, Acid Suppression, and Treatment of Recurrence

Leila Kia, Srinadh Komanduri*

*Corresponding author for this work

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Endoscopic eradication therapy is effective and durable for the treatment of Barrett's esophagus (BE), with low rates of recurrence of dysplasia but significant rates of recurrence of intestinal metaplasia. Identified risk factors for recurrence include age and length of BE before treatment and may also include presence of a large hiatal hernia, higher grade of dysplasia before treatment, and history of smoking. Current guidelines for surveillance following ablation are limited, with recommendations based on low-quality evidence and expert opinion. New modalities including optical coherence tomography and wide-area tissue sampling with computer-assisted analysis show promise as adjunctive surveillance modalities.

Original languageEnglish (US)
Pages (from-to)515-529
Number of pages15
JournalGastrointestinal Endoscopy Clinics of North America
Volume27
Issue number3
DOIs
StatePublished - Jul 1 2017

Keywords

  • Barrett's esophagus
  • Endoscopic eradication therapy
  • Endoscopic mucosal resection
  • Radiofrequency ablation
  • Surveillance

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Care of the Postablation Patient: Surveillance, Acid Suppression, and Treatment of Recurrence'. Together they form a unique fingerprint.

  • Cite this